Medline (MDLN) Shares Outstanding (2025 - 2026)

Medline (MDLN) has reported Shares Outstanding (Entity) for 2 consecutive years, with $1.3 billion the latest figure, recorded in Q2 2026.

• On a quarterly basis, Shares Outstanding (Entity) changed N/A year-over-year to $1.3 billion in Q2 2026; TTM through Jun 2026 was $1.3 billion, a N/A change from a year earlier, with the FY2025 full-year figure at $1.3 billion, changed N/A from the prior year.
• Shares Outstanding (Entity) was $1.3 billion for Q2 2026 at Medline, roughly flat from $1.3 billion in the prior quarter.
• Over five years, Shares Outstanding (Entity) peaked at $1.3 billion in Q2 2026 and troughed at $1.3 billion in Q1 2026.